Castleark Management’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.66M Buy
+23,790
New +$2.73M 0.07% 195

Other funds holding KYMR

Castleark Management's KYMR Position: Q3 2026 in Review

Castleark Management opened a new position in Kymera Therapeutics (KYMR) in Q3 2026: 23,790 shares worth $2.66M. The stake represents 0.07% of the portfolio and ranks #195 among its holdings.

301 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Castleark Management held 23,790 shares of Kymera Therapeutics worth $2.66M as of Q3 2026.
  • Kymera Therapeutics was a new Castleark Management position in Q3 2026.
  • Kymera Therapeutics made up 0.07% of Castleark Management's portfolio in Q3 2026, its #195 holding.
  • 301 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Castleark Management's 13F filing for Q3 2026, filed 16 Nov 2026.